1-Methyl-2-(methylsulfonyl)-1H-benzo[d]imidazole

Catalog No. :
ACSDET180
CAS No. :
61078-14-6
Molecular Formula :
C9H10N2O2S
Molecular Weight :
210.26

IUPAC Name:1-methyl-2-(methylsulfonyl)-1H-benzo[d]imidazole

1-Methyl-2-(methylsulfonyl)-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$184.00Login to see priceIn stockInquiry
10g97%$352.00Login to see priceIn stockInquiry
25g97%$737.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-2-(methylsulfonyl)-1H-benzo[d]imidazole
IUPAC Name1-methyl-2-(methylsulfonyl)-1H-benzo[d]imidazole
MDL No.MFCD01470564
Molecular FormulaC9H10N2O2S
Molecular Weight210.26
SMILESO=S(C1=NC2=CC=CC=C2N1C)(C)=O
InChI KeyVDZVTXFWEKBHBV-UHFFFAOYSA-N
SynonymCambridge id 5660811 | 1-Methyl-2-(methylsulfonyl)benzimidazole | CS-0370359 | InChI=1/C9H10N2O2S/c1-11-8-6-4-3-5-7(8)10-9(11)14(2,12)13/h3-6H,1-2H | HMS1378J16 | SCHEMBL9695987 | 1-methyl-2-methylsulfonylbenzimidazole | AKOS000563056 | ChemDiv2_003382 |
CAS No.61078-14-6
PubChem CID640715

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSDET180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAGMS826 route compound structure diagram
    ACAGMS82657159-81-6 In Stock
  4. Then
  5. ACSDET180 route product structure diagram
    ACSDET18061078-14-6 In Stock
Inquiry

2. ACSDET180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSDET180 route product structure diagram
    ACSDET18061078-14-6 In Stock
Inquiry

Comments (0)